GLP-1 medications have become an important option in medical weight management because they can influence appetite, fullness, food intake, and other biological processes involved in body weight regulation. For eligible patients, these medications may provide support beyond the initial stages of weight loss and can be used as part of a longer-term approach to managing obesity or overweight with certain weight-related health conditions.
Long-term weight management can be difficult because the body may respond to weight loss with increased hunger and changes in energy needs. Maintaining healthier eating habits can also become challenging when appetite and cravings return. GLP-1 medications may help address some of these factors, but they work best alongside nutrition, physical activity, and ongoing medical guidance. Zealthy provides an online medical weight loss program for eligible patients, combining provider-guided prescription care with coaching, nutrition and fitness support, and progress tracking.
How GLP-1 Medications Support Weight Management
GLP-1 medications work by activating pathways related to the naturally occurring hormone glucagon-like peptide-1. These pathways are involved in appetite regulation, digestion, and food intake. By influencing these signals, GLP-1 medications can help some people feel fuller and reduce how much they eat.
Lower hunger can make it easier to follow a reduced-calorie eating pattern. Instead of constantly trying to manage strong appetite signals through willpower alone, some patients may find that their hunger becomes more manageable during treatment.
Different medications can work in slightly different ways. Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GIP and GLP-1 receptors. The amount of weight loss and individual response can vary depending on the medication and the person receiving treatment.
Why Long-Term Weight Management Can Be Difficult
Losing weight and maintaining that loss are two related but different challenges. After weight loss, the body generally requires fewer calories to maintain its new weight. Changes in appetite can also make it more difficult for some people to maintain the eating habits that supported their initial progress.
This is one reason weight management may require ongoing support rather than a short-term diet. A temporary reduction in calories may produce weight loss, but maintaining the result often requires continued attention to nutrition, physical activity, appetite, and daily habits.
GLP-1 medications may provide additional biological support during this process. By helping regulate appetite and food intake, they can make healthy eating patterns more manageable for some eligible patients.
Long-term treatment should still be individualized. A healthcare provider can determine whether continuing medication is appropriate based on treatment response, side effects, health status, and overall goals.
What Research Shows About Long-Term GLP-1 Treatment
Clinical research provides evidence that some GLP-1 medications can support sustained weight loss when treatment continues over an extended period. One important example is the STEP 5 trial, which studied weekly semaglutide 2.4 mg in adults with overweight or obesity over 104 weeks.
After two years, participants receiving semaglutide experienced an average body-weight reduction of 15.2%, compared with 2.6% in the placebo group. About 77.1% of participants receiving semaglutide achieved at least 5% weight loss at week 104, compared with 34.4% receiving placebo.
The study also found that weight loss generally plateaued after around week 60 and remained relatively stable through week 104 among participants continuing treatment. These results suggest that continued semaglutide treatment can help support weight reduction over a period of two years, although individual results can differ considerably.
Appetite Control Can Support Long-Term Results
Appetite is one of the factors that can make long-term weight management challenging. When hunger remains high, maintaining a reduced-calorie diet may become increasingly difficult.
GLP-1 medications can help some people experience greater fullness and reduced hunger. Research involving semaglutide has also found improvements in aspects of eating control and food cravings during longer-term treatment.
This does not mean that GLP-1 medications completely eliminate hunger or cravings. People still need adequate nutrition, and appetite can vary throughout treatment. However, improved appetite control may make it easier to maintain reasonable portions and reduce unnecessary food intake.
Combining medication with practical nutrition strategies can make these benefits more useful in everyday life.
The Importance of Nutrition During Long-Term Treatment
Medication is only one part of a long-term weight management strategy. Nutrition continues to play an important role even when appetite is reduced.
A balanced eating pattern can include adequate protein, vegetables, fruits, whole grains, legumes, healthy fats, and other nutrient-dense foods. Choosing nutritious foods becomes especially important when overall food intake decreases because of reduced appetite.
Extreme calorie restriction is generally not necessary. Eating too little can make it harder to meet nutritional needs and may affect energy levels and overall well-being.
Instead, the focus can be on meals that provide good nutritional value while fitting within an individual’s calorie and health needs. Nutrition guidance from a qualified professional can help patients make appropriate choices throughout treatment.
Zealthy includes nutrition support within its online weight management services for eligible patients, helping individuals work on sustainable eating habits alongside provider-guided treatment.
Physical Activity Remains Important
GLP-1 medications can support weight management, but physical activity remains an important part of a healthy lifestyle. Regular movement can support cardiovascular health, strength, mobility, and overall fitness.
Aerobic activities such as walking, cycling, swimming, or other forms of movement can help increase daily activity. Resistance exercises can also support muscle strength and function, which may be particularly relevant during weight loss.
The most appropriate exercise routine depends on individual health and fitness levels. People who are new to exercise can start gradually and increase activity as their fitness improves.
Zealthy provides fitness support as part of its online weight management services for eligible patients. Combining movement with appropriate nutrition and medical treatment can create a broader approach to long-term weight management.
Can GLP-1 Medications Help Maintain Weight Loss
Maintaining weight loss can be challenging after a person reaches a lower weight. Appetite and other biological factors can continue to influence food intake, which may make maintaining previous results difficult.
Research from the STEP 5 trial suggests that continued semaglutide treatment can help maintain substantial weight reduction over two years. The average weight loss at week 104 was similar to the reduction seen around the one-year point, indicating relatively little average regain among participants who continued treatment.
The current prescribing information for Wegovy also identifies reducing excess body weight and maintaining weight reduction long term as part of its approved use for eligible adults.
However, this does not mean every person needs medication indefinitely. Treatment duration should be discussed with a healthcare provider, who can consider individual benefits, risks, side effects, and long-term goals.
What May Happen After Stopping Treatment
One important consideration with long-term weight management is what may happen after medication is discontinued. Research has shown that weight regain can occur after stopping semaglutide, which suggests that the underlying biological factors influencing weight do not necessarily disappear when treatment ends.
This does not mean that medication has failed. Weight management is influenced by many biological, environmental, and behavioral factors, and maintaining weight loss can require continued support.
If a patient is considering stopping a GLP-1 medication, the decision should be discussed with a healthcare provider. A provider can help evaluate current weight, appetite, lifestyle habits, treatment response, and possible alternatives before changes are made.
Stopping or changing prescription treatment without medical guidance is not recommended.
Weight Loss May Slow Over Time
It is normal for weight loss to change pace during a longer treatment period. Some people experience more noticeable weight reduction during the earlier stages and then reach a period where their weight changes more slowly.
The STEP 5 study found that semaglutide-related weight loss generally plateaued after approximately week 60 while remaining relatively stable through week 104.
A slower rate of weight loss does not automatically mean that treatment has stopped working. As body weight decreases, calorie requirements may also decrease, which can affect the rate of further weight reduction.
Healthcare providers can evaluate the overall trend rather than focusing on a short period of stable weight. They may review medication adherence, dosage, nutrition, physical activity, appetite, side effects, and other factors before deciding whether a treatment adjustment is needed.
Individual Results Can Vary
Clinical trial results provide useful information, but they cannot predict exactly how much weight one individual will lose. People respond differently to GLP-1 medications.
Starting weight, age, health conditions, genetics, nutrition, physical activity, medication dosage, treatment duration, and adherence can all influence outcomes. Some people may experience substantial weight loss, while others may have a more modest response.
The goal should therefore be based on realistic individual expectations rather than comparing personal progress with another person’s results.
A healthcare provider can help determine whether the amount and pace of weight loss are appropriate for your specific situation.
Side Effects and Medical Monitoring
GLP-1 medications can cause side effects, with gastrointestinal symptoms among the most common. These can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and changes in digestion.
Side effects may be more noticeable when treatment begins or when the dosage increases. In the STEP 5 study, gastrointestinal adverse events were reported more frequently with semaglutide than with placebo, although most were described as mild to moderate.
Medical monitoring is therefore important during long-term treatment. A healthcare provider can review side effects, treatment response, current medications, and other health factors to determine whether continuing treatment remains appropriate.
Patients should not increase, reduce, or stop a prescription medication on their own.
Why Ongoing Support Matters
Long-term weight management involves more than taking medication. Patients may need ongoing help with nutrition, physical activity, appetite changes, plateaus, and maintaining healthy routines.
Regular follow-up provides an opportunity to review progress and address concerns before they interfere with treatment. It can also help patients understand that occasional changes in weight are normal and do not necessarily indicate failure.
Coaching and lifestyle support can complement the effects of medication by helping patients develop habits that can continue over time.
Zealthy combines provider-guided prescription treatment with coaching, nutrition and fitness support, and progress tracking for eligible patients. This can provide ongoing assistance while patients work toward both weight loss and long-term weight maintenance.
How Zealthy Supports Long-Term Weight Management
Zealthy offers an online approach to medical weight management for eligible patients. The process can begin with an online health assessment, allowing a licensed healthcare provider to review relevant information about the patient’s health, weight, medications, and treatment goals.
If prescription treatment is medically appropriate, the provider can recommend a suitable option and provide guidance throughout treatment. Patients can discuss changes in appetite, side effects, weight progress, and other concerns with their care team.
Zealthy also provides nutrition and fitness support and progress tracking. Combining these services with medical care can help patients focus on sustainable habits rather than treating weight loss as a short-term project.
Ongoing guidance can be particularly useful when progress slows or treatment needs to be reassessed.
Final Thoughts
GLP-1 medications can support long-term weight loss for eligible patients by influencing appetite, fullness, food intake, and other biological processes involved in weight regulation. Clinical research has demonstrated that continued treatment with semaglutide can produce substantial and sustained weight reduction over two years.
Long-term success still involves more than medication. Balanced nutrition, regular physical activity, healthy daily habits, and ongoing medical supervision can all contribute to maintaining progress.
It is also important to recognize that results vary. Some people may lose significant amounts of weight, while others may experience more modest changes. Weight loss can slow or plateau over time, and continued treatment may be appropriate for some patients when the benefits outweigh the risks.
Zealthy provides online medical weight management for eligible patients, combining provider-guided prescription care with coaching, nutrition and fitness support, and progress tracking. This approach can help patients receive continued guidance while working toward sustainable weight management.
If you are considering a GLP-1 medication, speak with a licensed healthcare provider to determine whether treatment is appropriate for your health needs and to develop a long-term weight management plan.
